NASDAQ:LNCR - Lincare Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Lincare (NASDAQ:LNCR)

Lincare logoLincare Holdings Inc. (Lincare) is a provider of oxygen, respiratory and other chronic therapy services to patients in the home. The Company's customers suffer from chronic obstructive pulmonary disease (COPD), such as emphysema, chronic bronchitis or asthma, and require supplemental oxygen, respiratory and other chronic therapy services. As of December 31, 2011, the Company served more than 800,000 customers in 48 states of the United States and Canada through 1,108 operating centers. Lincare primarily provides oxygen, respiratory and other chronic therapy services to patients in the home. It also provides a variety of durable medical equipment (DME) and home infusion therapies in certain geographic markets. During the year ended December 31, 2011, the Company acquired companies that were contracted to provide home oxygen equipment and positive airway pressure devices. In August 2012, Lincare announced that The Linde Group completed its previously announced acquisition of the Company.

Receive LNCR News and Ratings via Email

Sign-up to receive the latest news and ratings for LNCR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Lincare (NASDAQ:LNCR) Frequently Asked Questions

What is Lincare's stock symbol?

Lincare trades on the NASDAQ under the ticker symbol "LNCR."

Has Lincare been receiving favorable news coverage?

News headlines about LNCR stock have been trending positive on Thursday, Accern Sentiment reports. The research group rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Lincare earned a media sentiment score of 0.46 on Accern's scale. They also gave news articles about the healthcare company an impact score of 45.01 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

How do I buy shares of Lincare?

Shares of LNCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Lincare?

Lincare's mailing address is 19387 US Highway 19 N, CLEARWATER, FL 33764-3102, United States. The healthcare company can be reached via phone at +1-813-5307700.

MarketBeat Community Rating for Lincare (LNCR)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  52 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  141
MarketBeat's community ratings are surveys of what our community members think about Lincare and other stocks. Vote "Outperform" if you believe LNCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LNCR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Lincare (NASDAQ:LNCR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/26/2016 forward)


Lincare (NASDAQ:LNCR) Earnings History and Estimates Chart

Earnings by Quarter for Lincare (NASDAQ:LNCR)

Lincare (NASDAQ LNCR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/16/2012$0.56$0.56ViewN/AView Earnings Details
4/16/2012$0.53$0.54ViewN/AView Earnings Details
2/6/2012$0.51$0.51ViewN/AView Earnings Details
10/17/2011$0.48$0.48ViewN/AView Earnings Details
7/18/2011$0.51$0.45ViewN/AView Earnings Details
4/18/2011$0.49$0.49ViewN/AView Earnings Details
2/7/2011$0.48$0.48ViewN/AView Earnings Details
10/18/2010Q3 2010$0.47$0.47ViewN/AView Earnings Details
7/19/2010Q2 2010$0.46$0.47ViewN/AView Earnings Details
4/19/2010Q1 2010$0.39$0.45ViewN/AView Earnings Details
2/8/2010Q4 2009$0.37$0.41ViewN/AView Earnings Details
10/19/2009Q3 2009$0.35$0.36ViewN/AView Earnings Details
7/20/2009Q2 2009$0.31$0.33ViewN/AView Earnings Details
4/20/2009Q1 2009$0.23$0.24ViewN/AView Earnings Details
2/9/2009Q4 2008$0.51$0.53ViewN/AView Earnings Details
10/20/2008Q3 2008$0.48$0.51ViewN/AView Earnings Details
7/21/2008Q2 2008$0.47$0.55ViewN/AView Earnings Details
4/21/2008Q1 2008$0.47$0.53ViewN/AView Earnings Details
2/11/2008Q4 2007$0.45$0.47ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Lincare (NASDAQ:LNCR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Lincare (NASDAQ LNCR) Insider Trading and Institutional Ownership History

Insider Trading History for Lincare (NASDAQ:LNCR)

Lincare (NASDAQ LNCR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Lincare (NASDAQ LNCR) News Headlines

No headlines for this company have been tracked by

SEC Filings

Lincare (NASDAQ:LNCR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Lincare (NASDAQ:LNCR) Income Statement, Balance Sheet and Cash Flow Statement


Lincare (NASDAQ LNCR) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.